BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

8722 related articles for article (PubMed ID: 15131409)

  • 21. Genetic testing for cancer predisposition.
    Eng C; Hampel H; de la Chapelle A
    Annu Rev Med; 2001; 52():371-400. PubMed ID: 11160785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Familial Pancreatic Cancer.
    Benzel J; Fendrich V
    Oncol Res Treat; 2018; 41(10):611-618. PubMed ID: 30269130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The yield of first-time endoscopic ultrasonography in screening individuals at a high risk of developing pancreatic cancer.
    Poley JW; Kluijt I; Gouma DJ; Harinck F; Wagner A; Aalfs C; van Eijck CH; Cats A; Kuipers EJ; Nio Y; Fockens P; Bruno MJ
    Am J Gastroenterol; 2009 Sep; 104(9):2175-81. PubMed ID: 19491823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Individuals at high-risk for pancreatic cancer development: management options and the role of surgery.
    Sakorafas GH; Tsiotos GG; Korkolis D; Smyrniotis V
    Surg Oncol; 2012 Jun; 21(2):e49-58. PubMed ID: 22244849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and genetic analysis of 18 pancreatic carcinoma/melanoma-prone families.
    Bartsch DK; Langer P; Habbe N; Matthäi E; Chaloupka B; Sina M; Hahn SA; Slater EP
    Clin Genet; 2010 Apr; 77(4):333-41. PubMed ID: 20041885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk Factors in Pancreatic Adenocarcinoma: the Interrelation with Familial History and Predictive Role on Survival.
    Petrusel L; Bilibou M; Drug V; Leucuta DC; Seicean R; Cainap C; Seicean A
    J Gastrointestin Liver Dis; 2020 Sep; 29(3):391-398. PubMed ID: 32919422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Familial pancreatic cancer syndromes.
    Habbe N; Langer P; Sina-Frey M; Bartsch DK
    Endocrinol Metab Clin North Am; 2006 Jun; 35(2):417-30, xi. PubMed ID: 16632103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Risk factors and early diagnosis of pancreatic cancer].
    López Serrano A
    Gastroenterol Hepatol; 2010 May; 33(5):382-90. PubMed ID: 20005016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for a major gene influencing risk of pancreatic cancer.
    Klein AP; Beaty TH; Bailey-Wilson JE; Brune KA; Hruban RH; Petersen GM
    Genet Epidemiol; 2002 Aug; 23(2):133-49. PubMed ID: 12214307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A histomorphologic comparison of familial and sporadic pancreatic cancers.
    Singhi AD; Ishida H; Ali SZ; Goggins M; Canto M; Wolfgang C; Meriden Z; Roberts N; Klein AP; Hruban RH
    Pancreatology; 2015; 15(4):387-391. PubMed ID: 25959245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluating Susceptibility to Pancreatic Cancer: ASCO Provisional Clinical Opinion.
    Stoffel EM; McKernin SE; Brand R; Canto M; Goggins M; Moravek C; Nagarajan A; Petersen GM; Simeone DM; Yurgelun M; Khorana AA
    J Clin Oncol; 2019 Jan; 37(2):153-164. PubMed ID: 30457921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions.
    Lancaster JM; Powell CB; Kauff ND; Cass I; Chen LM; Lu KH; Mutch DG; Berchuck A; Karlan BY; Herzog TJ;
    Gynecol Oncol; 2007 Nov; 107(2):159-62. PubMed ID: 17950381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective results of surveillance colonoscopy in dominant familial colorectal cancer with and without Lynch syndrome.
    Dove-Edwin I; de Jong AE; Adams J; Mesher D; Lipton L; Sasieni P; Vasen HF; Thomas HJ
    Gastroenterology; 2006 Jun; 130(7):1995-2000. PubMed ID: 16762622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical heterogeneity of familial colorectal cancer and its influence on screening protocols.
    Vasen HF; Taal BG; Griffioen G; Nagengast FM; Cats A; Menko FH; Oskam W; Kleibeuker JH; Offerhaus GJ; Khan PM
    Gut; 1994 Sep; 35(9):1262-6. PubMed ID: 7959234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Germline mutation prevalence in individuals with pancreatic cancer and a history of previous malignancy.
    Dudley B; Karloski E; Monzon FA; Singhi AD; Lincoln SE; Bahary N; Brand RE
    Cancer; 2018 Apr; 124(8):1691-1700. PubMed ID: 29360161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Familial pancreatic cancer and hereditary syndromes: screening strategy for high-risk individuals.
    Matsubayashi H
    J Gastroenterol; 2011 Nov; 46(11):1249-59. PubMed ID: 21847571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Familial pancreatic cancer.
    Hruban RH; Petersen GM; Goggins M; Tersmette AC; Offerhaus GJ; Falatko F; Yeo CJ; Kern SE
    Ann Oncol; 1999; 10 Suppl 4():69-73. PubMed ID: 10436789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosis and Management of Hereditary Pancreatic Cancer.
    Humphris JL; Biankin AV
    Recent Results Cancer Res; 2016; 205():61-83. PubMed ID: 27075349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implications and issues related to familial pancreatic cancer: a cohort study of hospitalized patients.
    Mughetti M; Calculli L; Chiesa AM; Ciccarese F; Rrusho O; Pezzilli R
    BMC Gastroenterol; 2016 Jan; 16():6. PubMed ID: 26767414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hereditary cancer in adults.
    Lynch HT; Fusaro RM; Lynch J
    Cancer Detect Prev; 1995; 19(3):219-33. PubMed ID: 7750110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 437.